
A tumor marker used mainly to monitor the effectiveness of treatment and follow up on cancer recurrence.
Description of Blood Analysis:
Carcinoembryonic Antigen (CEA) is a complex glycoprotein produced by the digestive system tissues during the embryonic period. In a healthy adult, the synthesis of this protein is largely blocked, resulting in extremely low concentrations in the blood. A rise in CEA levels serves as a biochemical signal of cellular metabolism transformation. In clinical practice, this marker is used as a specific indicator of tissue biological activity, helping the physician analyze the stability of the body’s condition.
What does the analysis represent?
Recommendations for the Test (General)
What can affect the results?
When to take the test?
How to interpret the results?
Numerical interpretation is the physician’s professional task. The CEA value is never an isolated verdict. The specialist analyzes it alongside complaints, colonoscopy or gastroscopy results, and CT or MRI data. Self-interpretation is prohibited, as deviations may be due to benign factors that only an expert can evaluate.
Possible further investigations
When does the next step make sense?
If a CEA analysis is done for GI organ monitoring, results are assessed by a doctor alongside exam data and instrumental diagnostics. Further medical strategies are determined individually for each patient based on all the data.
👉 If necessary, you can discuss the analysis results with a specialist such as a gastroenterologist ( Doctors – TAMC ) or oncology ( Doctors – TAMC ).